Anebulo Pharmaceuticals, Inc.
ANEB
$2.30
-$0.01-0.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.93% | -8.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.18% | -26.89% | |||
| Operating Income | -23.18% | 26.89% | |||
| Income Before Tax | -27.96% | 31.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.96% | 31.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.96% | 31.94% | |||
| EBIT | -23.18% | 26.89% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -27.94% | 54.57% | |||
| Normalized Basic EPS | -27.84% | 54.63% | |||
| EPS Diluted | -27.94% | 54.57% | |||
| Normalized Diluted EPS | -27.84% | 54.63% | |||
| Average Basic Shares Outstanding | 0.00% | 49.86% | |||
| Average Diluted Shares Outstanding | 0.00% | 49.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||